INGN Q4 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$80M+5.5% YoY

Gross Profit

$36M45.3% margin

Operating Income

-$11M-14.2% margin

Net Income

-$10M-12.2% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$296M

Total Liabilities

$122M

Stockholders' Equity

$174M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$76M	+5.5%
Gross Profit	$36M	$28M	+28.9%
Operating Income	-$11M	-$29M	+60.7%
Net Income	-$10M	-$27M	+63.3%

Geographic Segments

UNITED STATES

$110M65%

Non-US

$59M35%